Dr. Jonathan Willmer

• 
  www.virtusclinicaldevelopment.com/profile-people-board. - [Cached Version]
  Published on: 9/28/2008    Last Visited: 9/28/2008  

  Dr. Jonathan Willmer M.D., FRCP (C) Jonathan obtained his MD degree from Queen's University, Kingston, Ontario, Canada in 1980 and was certified in neurology by the Royal college of Physicians and Surgeons of Canada in 1985.He held a position in the faculty of Medicine at the University of Ottawa, Ottawa, Canada, as an assistant professor, where he ran a clinical research program in Alzheimer's disease and dementia.For twelve years he ran a clinical trials unit in dementia, conducting clinical trials in all phases of development.Jonathan currently holds the position of Chief Medical Officer, Prime Trials Inc., a clinical pharmacology unit in Vancouver, British Columbia, Canada. Prior to this he held the positions of Vice President, medical Affairs and Vice President, Clinical development for CroMedica Global Inc., a global CRO.In these roles he was responsible for the integration of CroMedica's global medical operations team and led CroMedica's early clinical development programs worldwide.

• 
  www.networkimmunologyinc.com/?page_id=5 - [Cached Version]
  Published on: 9/24/2008    Last Visited: 9/24/2008  

  Dr. Jonathan Willmer, Director
  
  Dr. Willmer currently holds the position of Chief Medical Officer, Neurokine Pharmaceuticals Inc. a start up biotechnology company located in Vancouver, British Columbia, Canada.The company focuses on development of treatments for chronic inflammatory and degenerative central nervous system diseases.
  
  Prior to this he held the positions of Vice President, Medical Affairs and Vice President, Clinical Development for CroMedica Global Inc., a global CRO.In these roles he was responsible for the integration of CroMedica's global medical operations team and led CroMedica's early clinical development programs worldwide.He oversaw the construction of and supervised the operation of CroMedica Prime, a phase 1 unit located in the Vancouver Hospital and Health Sciences Center, the major teaching hospital of the University of British Columbia.
  
  Prior to joining CroMedica, Dr. Willmer ran a clinical and research program in Alzheimer's disease and dementia at the University of Ottawa (Ottawa, Ontario, Canada).For twelve years he ran a clinical trials unit in dementia, conducting trials in all phases of development.He also held a position in the Faculty of Medicine as an assistant professor.Dr. Willmer obtained his MD degree from Queen's University (Kingston, Ontario, Canada) in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.

• 
  www.canreg.ca/popup/pages/jonw.html - [Cached Version]
  Published on: 12/31/2002    Last Visited: 9/30/2003  

  Jonathan Willmer, MD, Chief Medical Officer., Prime Trials
  ...
  Jonathan Willmer MD
  
  Jonathan Willmer, MD, Chief Medical Officer, Prime Trials has held the positions of Vice President, Medical Affairs and Vice President, Clinical Development for CroMedica Global Inc. a global CRO, prior to assuming his current role.In these roles he was responsible for the integration of CroMedica's global medical operations team and led CroMedica's early clinical development programs worldwide.Dr. Willmer oversaw the construction of and supervised the operation of CroMedica Prime.For 12 years he ran a clinical trials unit in dementia, conducting trials in all phases of development.He also held a position in the Faculty of Medicine as an assistant professor at the University of Ottawa.Dr. Willmer obtained his MD degree from Queen's University, Kingston Ontario, Canada, in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.

• 
  Axelson Biopharma Research Inc. - [Cached Version]
  Published on: 3/30/2001    Last Visited: 3/4/2005  

  The new partnership has also involved the creation of a new and expanded board of directors, which includes Dr. Donald B. Rix, Chairman and Director of CANTEST and Chairman of MDS Metro Laboratory Services, and Dr. Jonathan Willmer, VP Clinical Development at CroMedica Global Inc.

• 
  BioFuture Conference and Exhibition - [Cached Version]
  Published on: 8/9/2000    Last Visited: 3/19/2001  

  Dr. Jonathan WillmerCroMedica Global IncAbstract Title : The Advantages of Executing Phase 1 Research in Canada

• 
  CanTest Clinical Research - [Cached Version]
  Published on: 11/19/2006    Last Visited: 2/13/2008  

  Dr. Jonathan WillmerChief Medical Officer
  ...
  Dr. Jonathan Willmer

• 
  Cantest - Medical Staff - [Cached Version]
  Published on: 9/26/2007    Last Visited: 12/29/2007  

  Dr. Jonathan Willmer, has been the clinical leader of CANTEST Clinical Research (formerly Prime Trials) since its inception as CroMedica Global and has over 24 years of experience.Dr. Willmer was Vice President of Medical Affairs and Vice President of Clinical Development for CroMedica Global Inc. prior to assuming his current role.In these roles he was responsible for the integration of CroMedica's Global Medical Operations team and led CroMedica's early clinical development programs worldwide.He oversaw the construction and operation of CroMedica Prime.For 12 years he ran a clinical trials unit in dementia, conducting trials in all phases of development.He has also held a position in the Faculty of Medicine as an Assistant Professor at the University of Ottawa.Dr. Willmer obtained his MD degree from Queen's University (Kingston, Ontario, Canada) in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.

• 
  Cantest - Medical Staff - [Cached Version]
  Published on: 10/13/2008    Last Visited: 1/10/2008  

  Dr. Jonathan Willmer, has been the clinical leader of CANTEST Clinical Research (formerly Prime Trials) since its inception as CroMedica Global and has over 24 years of experience.Dr. Willmer was Vice President of Medical Affairs and Vice President of Clinical Development for CroMedica Global Inc. prior to assuming his current role.In these roles he was responsible for the integration of CroMedica's Global Medical Operations team and led CroMedica's early clinical development programs worldwide.He oversaw the construction and operation of CroMedica Prime.For 12 years he ran a clinical trials unit in dementia, conducting trials in all phases of development.He has also held a position in the Faculty of Medicine as an Assistant Professor at the University of Ottawa.Dr. Willmer obtained his MD degree from Queen's University (Kingston, Ontario, Canada) in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.

• 
  CroMedica - NEWS: CroMedica News : InPhase Newsletter... - [Cached Version]
  Published on: 5/1/1999    Last Visited: 1/13/2002  

  Jonathan Willmer, MD, FRCP(C) Vice President, Clinical Development is a neurologist with expertise in neuropathology, dementia, and sleep disorders.His focus is early clinical development of new therapeutic agents and he has acted as Principal Investigator on a number of phase I trials.Dr. Willmer leads CroMedica Prime, our phase I/IIa special investigations unit located in the Vancouver General Hospital.He is on staff at the Memory Disorders Clinic in Victoria, Canada.

• 
  Free Evening Seminar - [Cached Version]
  Published on: 11/1/2005    Last Visited: 4/12/2006  

  Dr. Jonathan WillmerPrime Trials Inc., Vancouver, Canada
  
  Dr. Jonathan Willmer currently holds the position of Chief Medical Officer, Prime Trials Inc. (formerly CroMedica Prime), a clinical pharmacology unit located in Vancouver, British Columbia, Canada.
  
  Prior to this he held the positions of Vice President, Medical Affairs and Vice President, Clinical Development for CroMedica Global Inc., a global CRO.In these roles he was responsible for the integration of CroMedica's global medical operations team and led CroMedica's early clinical development programs worldwide.He oversaw the construction of and supervised the operation of CroMedica Prime, a phase 1 unit located in the Vancouver Hospital and Health Sciences Center, the major teaching hospital of the University of British Columbia.
  
  Prior to joining CroMedica, Dr. Willmer ran a clinical and research program in Alzheimer's disease and dementia at the University of Ottawa (Ottawa, Ontario, Canada).For twelve years he ran a clinical trials unit in dementia, conducting trials in all phases of development.He also held a position in the Faculty of Medicine as an assistant professor.Dr. Willmer obtained his MD degree from Queen's University (Kingston, Ontario, Canada) in 1980, and was certified in neurology by the Royal College of Physicians and Surgeons of Canada in 1985.
  
  Who Should Attend

Page:  1 2